Company Analysis

AnaptysBio, Inc. (ANAB)

Nasdaq: ANAB · Pharmaceutical Preparations · San Diego, CA · filing with the SEC since 2006
Grade6.4
◀ Past 6.1● Present 6.3▶ Future 6.7
3 est.

Income statement, as filed

In thousands of US dollars (USD), as filed; per-share figures in US dollars; share counts in thousands. The fiscal year ends in June.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period endingDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016
Report filedMar 3, 2026Feb 27, 2025Mar 11, 2024Mar 1, 2023Mar 7, 2022Feb 25, 2021Mar 2, 2020Feb 28, 2019Mar 5, 2018Mar 8, 2017
Revenue234,60391,28017,15710,28763,17575,0008,0005,00010,00016,684
Research and development135,970163,840132,28388,79898,49680,02599,33856,19629,44315,419
General and administrative11,345r13,633r41,94636,64321,49318,85416,09415,5269,3384,290
Total operating expenses7,701r25,128r181,568125,441119,98998,879115,43271,72238,78119,709
Operating income226,902r66,152r-164,411-115,154-56,814-23,879-107,432-66,722-28,781-3,025
Interest expense····001,0411,6521,775458
Interest and investment income9,813r15,074r18,8737,5504313,95910,9846,6851,623127
Other income (expense), net5,453r0r-21237-111-159229-147
Total non-operating income (expense)-64,627r-35,013r788-13,546-9823,9489,9444,874-1,289-1,234
Income before income taxes162,275r31,139r-163,623-128,700-57,796-19,931-97,488-61,848-30,070-4,259
Income tax expense772r158r-42400-152-19200
Income from continuing operations161,50330,981········
Income from discontinued operations-174,735-176,212········
Net income-13,232-145,231-163,619-128,724-57,796-19,931-97,336-61,656-30,070-4,259
Net income to common shareholders······-97,336-61,656-30,070-4,259
Earnings per share, basic-0.46-5.12-6.08-4.57-2.11-0.73-3.60-2.50-1.52-1.62
Earnings per share, diluted-0.44r-4.92r-6.08-4.57-2.11-0.73-3.60-2.50-1.52-1.62
Earnings per share, basic and diluted·····-0.73-3.60-2.50-1.52-1.62
Weighted average shares, basic28,75828,38226,92428,16527,43127,30227,059···
Weighted average shares, diluted30,233r29,544r26,92428,16527,43127,30227,059···
Weighted average shares, basic and diluted·····27,30227,05924,67319,7822,637
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax
us-gaap:SalesRevenueNet
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
us-gaap:ResearchAndDevelopmentExpense
General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense
Total operating expenses the running costs togetherus-gaap:OperatingExpenses
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest expense what its borrowing costus-gaap:InterestExpense
Interest and investment income what its cash and investments earnedus-gaap:InterestIncomeOther
us-gaap:InvestmentIncomeInterest
Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense
Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense
Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Income from continuing operations profit from the businesses it keepsus-gaap:IncomeLossFromContinuingOperations
Income from discontinued operations profit or loss from businesses it sold or closedus-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Net income to common shareholders what is left for common shareholdersus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Earnings per share, basic and diluted net income per share, where both counts are the sameus-gaap:EarningsPerShareBasicAndDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Weighted average shares, basic and diluted the average count, where both counts are the sameus-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
SI Assistanton ANAB · research, not advice